
How do cannabis businesses access capital when banks won't lend?
Most raise capital through a specialized network of cannabis-friendly lenders, equity investors, real estate capital providers, grant programs and strategic partners. Funding Buds assesses whether your business is ready to raise, builds the capital strategy, and introduces you to sources that fit your stage, license type and state.

Need the model, deck or deal terms? Funding Buds finds the capital. Our Financing Advisory team builds the financial model and investor materials, structures the terms and runs due diligence. Most raises use both.
Federal prohibition locks most cannabis operators out of traditional financing, and cannabis-specific lenders’ terms vary widely. We connect operators with capital sources vetted for cannabis exposure and match them to the right capital structure for their stage, license type and state. For building the financial model, structuring terms and managing due diligence, see Financing Advisory.
What’s included
Debt financing
Cannabis-friendly lenders, equipment financing and working capital lines.
Real estate capital
Sale-leaseback, construction loans and facility financing.
Equity raises
Private placements, family offices and institutional investors.
Grant programs
Social equity grants and state-sponsored funding opportunities.
Growth capital
Expansion funding for new licenses and market entry.
Cannabis funding challenges we help with
- Traditional banks won’t lend to cannabis businesses because of federal status.
- Terms from cannabis-specific lenders vary widely, and some are expensive without careful negotiation.
- Investors require clean financials that many operators struggle to produce.
- 280E reduces after-tax cash flow and makes debt service harder for activity it still applies to.
- Valuation methods vary widely across the cannabis industry.
How we work
Financial assessment
We review your financials, cash flow and capital needs, and tell you plainly whether you are ready to raise.
Capital strategy
We develop the funding mix that fits your growth plans and risk tolerance.
Investor materials
Our financing advisory team builds the pitch deck, financial model and diligence package.
Introductions
We connect you with vetted cannabis-friendly capital sources.
Deal support
We support negotiation and closing through funding.
Who it’s for
Licensed operators seeking growth capital, refinancing existing debt, financing real estate or equipment, or preparing for a first institutional raise.
Why it matters for cannabis operators
Capital providers price federal policy risk into every cannabis deal. State-licensed medical cannabis moved to Schedule III on April 28, 2026 (the order is being challenged in court). The DEA has so far registered only medical-only dispensaries, and the IRS hasn’t said whether 280E relief depends on that registration, so medical-only operators are in the clearest position, while relief for operators with both medical and adult-use licenses is unresolved. Adult-use cannabis remains Schedule I pending the DEA administrative law judge’s recommendation, so 280E still applies to it. Expect lenders and investors to ask how your business splits between the two. See our rescheduling tracker for the latest status.
Frequently asked questions
What does Funding Buds do?
Funding Buds helps cannabis operators find and secure the capital they need to operate and grow. Many operators enter the industry for the product or the mission, not for capital markets experience, so we lead the funding work while you run the business. We assess readiness, set the capital strategy, identify the right lenders and investors, make introductions and support you through closing.
What is capital advisory?
Capital advisory looks at your whole capital picture rather than just the next round. We review your current capital structure, measure the gap between the capital you have and what the plan requires, weigh the trade-offs between capital sources, and plan the sequence of capital events over several years. Cannabis capital markets work differently from general small-business markets, so this work depends on knowing which sources are active in cannabis.
What capital sources can Funding Buds help me reach?
Cannabis-friendly lenders and working capital lines, equipment financing, sale-leaseback and construction financing for real estate, private placements, family offices, cannabis-focused equity funds, strategic investors from within the industry, and social equity grants and state funding programs. Part of the value is reaching sources that are not publicly visible or that require an introduction. Many operators end up with a mix of debt and equity rather than a single source.
Why is it harder for cannabis businesses to raise capital?
Five reasons. Most traditional lenders, including major banks, will not lend to cannabis businesses regardless of state legality. The pool of cannabis-focused capital is smaller, which limits providers and terms. Federal policy is still changing, and some capital providers price that uncertainty heavily or stay away. 280E reduces after-tax cash flow for activity it still applies to. And state review of ownership changes can complicate deal timing.
How do you match a business with the right capital sources?
We start with what you need: how much capital, the use of proceeds, your willingness to take on dilution or debt, timing, and how involved you want investors to be after closing. We then match that against sources by stage preference, vertical focus, geography, check size and operating style. We filter out poor fits before any meeting and make warm introductions instead of sending you into cold outreach.
Do you help with cannabis loans and debt financing?
Yes. We identify lenders actively serving cannabis businesses, prepare the materials they require, shape the loan request to match lender preferences, help negotiate terms and support closing. Fewer lenders serve cannabis and terms are usually tighter, so choosing the right lender matters more. Lenders also expect regular reporting after closing, and our accounting team keeps that reporting in the form lenders expect.
Do you work with cannabis venture capital and private equity?
Yes. We identify funds whose strategy fits your business, prepare you for fund diligence, which is usually much more rigorous than angel diligence, and help negotiate terms that reflect cannabis market conditions. We also help you decide whether institutional capital fits at all, because it comes with governance and exit expectations that may not match your goals. Sometimes the right advice is a different kind of capital.
What should be in place before we approach lenders or investors?
Clean, current books; documented 280E tax positions; clear licensing status; a demonstrated compliance record; and a defined ask covering amount, use of proceeds, valuation expectations and acceptable terms. Cannabis investors examine these areas closely, and operators who arrive without them usually get polite declines. If gaps exist, we scope the readiness work first and the raise second.
How does Funding Buds work with the Fractional CFO service?
Our Fractional CFO service covers fundraising strategy, conversations with banks and investors, and planning for growth, expansion or a merger. When you use both, Funding Buds leads source identification and the raise, while the Fractional CFO handles internal financial strategy, how the new capital is deployed, and investor reporting after closing. Capital without a plan to deploy it well can hurt your credibility for the next round.
How is Funding Buds priced?
We quote each engagement after scoping it. Pricing depends on whether the work is a defined project, such as a readiness review, or ongoing capital advisory that continues through the raise and after. You work directly with a senior advisor throughout.
How do I get started with Funding Buds?
Start with a confidential conversation about how much capital you need, why, your timeline, the type of capital you prefer and how involved you want investors to be. We give you a frank view of whether the business is ready to raise. You then get a proposed scope with a named senior advisor, and our tax, accounting and advisory teams contribute where needed without separate engagements.